COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Submitted: 22 April 2020
Accepted: 18 July 2020
Published: 19 November 2020
Accepted: 18 July 2020
Abstract Views: 1391
PDF: 946
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S.L. Bello, L. Serafino, C. Bonali, N. Terlizzi, C. Fanizza, C. Anecchino, G. Lapaldula, Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents , Reumatismo: Vol. 64 No. 5 (2012)
- A. Loi, S. Lisci, A. Denotti, A. Cauli, Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment , Reumatismo: Vol. 65 No. 3 (2013)
- A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti, Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review , Reumatismo: Vol. 65 No. 2 (2013)
- M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni, Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients , Reumatismo: Vol. 65 No. 6 (2013)
- A. Alciati, F. Atzeni, P. Sgiarovello, P. Sarzi-Puttini, Somatoform disorders and rheumatic diseases: from DSM-IV to DSM-V , Reumatismo: Vol. 66 No. 1 (2014)
- S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli, Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients , Reumatismo: Vol. 64 No. 6 (2012)
- Y. Ragab, M. Nabih, I. Aly, A. Kamal, M. A. Abd-Allah, R. El-Refai, Y. Emad, A. El-Naggar, N. El-Shaarawy, J.J. Rasker, Magnetic resonance imaging features of hip disorders in an Egyptian pediatric population , Reumatismo: Vol. 67 No. 2 (2015)
- S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso, IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report , Reumatismo: Vol. 64 No. 1 (2012)
- A. Minelli, A. Vaona, Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review , Reumatismo: Vol. 64 No. 3 (2012)
- L. Cantarini, A. Vitale, O.M. Lucherini, I. Muscari, F. Magnotti, G. Brizi, B. Frediani, G.D. Sebastiani, M. Galeazzi, D. Rigante, Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined , Reumatismo: Vol. 65 No. 2 (2013)
You may also start an advanced similarity search for this article.